MNOV

Medicinova Stock Price

5.71
0.12 (2.15%)
Upgrade to Real-Time
Afterhours (Closed)
5.71
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Medicinova Inc MNOV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.12 2.15% 5.71 20:00:00
Close Price Low Price High Price Open Price Previous Close
5.71 5.44 5.72 5.57 5.59
Bid Price Ask Price Spread News
5.60 6.00 0.40 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,096 208,757 $ 5.64 $ 1,176,367 816,149 2.79 - 13.25
Last Trade Time Type Quantity Stock Price Currency
18:03:55 2 $ 5.75 USD

Medicinova Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 256.54M 44.93M 42.59M $ - $ - -0.29 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 14.00k 6.90%

more financials information »

Medicinova News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNOV Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.405.725.335.51174,9090.315.74%
1 Month5.215.725.05435.40169,6260.509.6%
3 Months7.029.654.6315.73529,380-1.31-18.66%
6 Months5.6413.254.6319.141,030,6960.071.24%
1 Year7.4313.252.798.74584,131-1.72-23.15%
3 Years7.2514.502.799.08282,239-1.54-21.24%
5 Years2.9514.502.74498.60206,7202.7693.56%

Medicinova Description

MediciNova Inc is a biopharmaceutical company. It acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of small molecule therapeutics segment.


Your Recent History
NASDAQ
MNOV
Medicinova
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.